Velarion Records
Free. Unsubscribe any time.

ANI PHARMACEUTICALS INC (ANIP)

ANI PHARMACEUTICALS INC filed 43 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 46 transactions and 77,506 shares. None carries the SEC's AFF10B5ONE flag; all 43 name a plan in a footnote. 16 results prints are on file in the same window.

What stands out

Trades in ANI PHARMACEUTICALS INC 46

Adoption dates in ANI PHARMACEUTICALS INC 10

Results prints in ANI PHARMACEUTICALS INC 16

Trades before a print in ANI PHARMACEUTICALS INC 3

Interval to ANI PHARMACEUTICALS INC’s next reported results date

How the interval and sources are counted →

Adoption dates ANI PHARMACEUTICALS INC states

Filing text: “10b5-1 trading plan adopted by the reporting person on March 9, 2026”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.